Bulletin # | Date | Topics | Type | BT201727 | 04/18/2017 | IHCP revises reimbursement policy for vaccines purchased outside the VFC program | All |
BT201726 | 04/13/2017 | IHCP publishes an Outpatient Fee Schedule | All |
BT201725 | 04/06/2017 | IHCP revises Hospital Assessment Fee adjustment factor for inpatient DRG base rate | All, Hospitals |
BT201724 | 03/30/2017 | April 2017 quarterly HCPCS code updates announced | All |
BT201723 | 03/28/2017 | IHCP revises coverage policies for home health services | Home Health, DME |
BT201722 | 03/23/2017 | IHCP revises Hospital Assessment Fee adjustment factor for outpatient rates | All, Hospitals |
BT201721 | 03/14/2017 | High-risk providers must comply with fingerprint-based criminal background checks by March 30 | All |
BT201720 | 03/14/2017 | Coverage for cervical cancer screenings revised to follow USPSTF and ASCCP guidelines | All |
BT201719 | 03/14/2017 | IHCP clarifies Presumptive Eligibility for incarcerated individuals | All |
BT201718 | 02/28/2017 | IHCP notifies HCBS providers of inappropriate TPL reclamation process for HCBS claims | Waiver, All |
BT201717 | 02/28/2017 | Changes to fee-for-service pharmacy benefit reimbursement methodology | Pharmacy, Prescribing |
BT201716 | 02/28/2017 | Pharmacy update approved by Drug Utilization Review Board February 2017 | Pharmacy, Prescribing |
BT201715 | 02/14/2017 | IHCP provides additional claim-related guidance for the new CoreMMIS | All |
BT201714 | 02/14/2017 | OBSOLETE: IHCP establishes PA criteria for sinus surgery | All |
BT201713 | 02/14/2017 | MDwise no longer serving Hoosier Care Connect members effective April 1, 2017 | All |
BT201712 | 02/10/2017 | IHCP to update the Fee Schedule with CoreMMIS implementation | All |
BT201711 | 02/10/2017 | Find key CoreMMIS and Provider Healthcare Portal bulletins, training, and resources here! | All |
BT201710 | 01/30/2017 | IHCP sets new CoreMMIS implementation date of February 13, 2017 | All |
BT201709 | 01/26/2017 | IHCP to cover HCPCS code T1029 – Comprehensive environmental lead investigation | All, Public Health Agency |
BT201708 | 01/26/2017 | IHCP revises PDL status for hydroxyprogesterone caproate | Pharmacy, Prescribing |